Literature DB >> 9181167

Propofol induces a lowering of free cytosolic calcium in myocardial cells.

Y C Li1, P Ridefelt, L Wiklund, G Bjerneroth.   

Abstract

BACKGROUND: The intravenous anaesthetic drug propofol has been shown to depress myocardial contractility. Ketamine, on the other hand, is a well-documented cardiovascular stimulant. These differences could possibly be due to different effects of the drugs on the calcium homeostasis of the myocardium.
METHODS: The fluorescent intracellular probe fura-2 acetoxymethyl ester (fura-2/AM) was used in this in vitro investigation to study the influence of intravenous anaesthetic drugs on free cytosolic calcium concentration in suspensions of isolated rat myocardial cells.
RESULTS: Addition of 0.5-2.0 micrograms/mL propofol resulted in a significant and dose-dependent decrease of free cytosolic calcium concentration in the myocardial cells, while addition of 0.25-2.5 micrograms/mL ketamine did not affect this concentration significantly.
CONCLUSION: The results imply that the previously demonstrated negative inotropic effect of propofol could possibly be related to its influence on calcium availability in the myocardium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9181167     DOI: 10.1111/j.1399-6576.1997.tb04756.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  12 in total

1.  The differential effect of propofol on contractility of isolated myocardial trabeculae of rat and guinea-pig.

Authors:  J van Klarenbosch; G J Stienen; W de Ruijter; G J Scheffer; J J de Lange
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 2.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

3.  Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion.

Authors:  Nicola King; Madj Al Shaama; M-Saadeh Suleiman
Journal:  Pflugers Arch       Date:  2012-09-22       Impact factor: 3.657

Review 4.  Propofol for sedation in neuro-intensive care.

Authors:  Michael P Hutchens; Stavros Memtsoudis; Nicholas Sadovnikoff
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 5.  Strategies to optimise propofol-opioid anaesthesia.

Authors:  Bart-Jan Lichtenbelt; Martijn Mertens; Jaap Vuyk
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  In vivo and ex vivo effects of propofol on myocardial performance in rats with obstructive jaundice.

Authors:  Hong-Mei Ren; Li-Qun Yang; Zhi-Qiang Liu; Cai-Yang Chen; Chi-Wai Cheung; Kun-Ming Tao; Jian-Gang Song; Wu-Rong Chen; Wei-Feng Yu
Journal:  BMC Gastroenterol       Date:  2011-12-28       Impact factor: 3.067

Review 7.  Cardiopulmonary bypass and oxidative stress.

Authors:  Mustafa Zakkar; Gustavo Guida; M-Saadeh Suleiman; Gianni D Angelini
Journal:  Oxid Med Cell Longev       Date:  2015-02-04       Impact factor: 6.543

8.  Sevoflurane exerts improved protective effects than propofol on hypoxia-reoxygenation injury by regulating the microRNA-221-5p/ADAM8 axis in cardiomyocytes.

Authors:  Dan Xie; Huifei Deng; Hao Feng
Journal:  Exp Ther Med       Date:  2021-06-18       Impact factor: 2.447

9.  The effects of propofol cardioplegia on blood and myocardial biomarkers of stress and injury in patients with isolated coronary artery bypass grafting or aortic valve replacement using cardiopulmonary bypass: protocol for a single-center randomized controlled trial.

Authors:  Zoe E Plummer; Sarah Baos; Chris A Rogers; M-Saadeh Suleiman; Alan J Bryan; Gianni D Angelini; James Hillier; Richard Downes; Eamonn Nicholson; Barnaby C Reeves
Journal:  JMIR Res Protoc       Date:  2014-07-08

10.  Propofol protects the immature rabbit heart against ischemia and reperfusion injury: impact on functional recovery and histopathological changes.

Authors:  Makoto Shirakawa; Hajime Imura; Takashi Nitta
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.